Next Generation Sequencing Market 2023 Outlook | BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., etc Key Players

Market Highlights

The novel DNA sequencing methods are known as next-generation sequencing methods or high throughput sequencing methods deliver a high rate of throughputs that can yield a huge volume of sequences with many applications in clinical research, forensics, agriculture, and others. Key players involved in next-generation sequencing data are undergoing strategic alliances in order to grow their current product portfolio, in the meantime maintain a competitive edge in the market. The alliances are basically focused on developing advanced infrastructure solutions thus empowering researchers to perform a population-scale genomic analysis.

Factors such as increasing technological advancements, increasing awareness, growing acquisitions and mergers among the players. to build capital for new innovations and rise in genome mapping programs boost the growth of the market exponentially. However, factors such as infrastructure, skilled workforce to manage and store huge amount of data appropriately, and the high cost involved in the technology, restrain the market from growth.

Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/6354

Key Players for Global Next Generation Sequencing Market

Market Research Future (MRFR) recognizes the following companies as the key players in Next Generation Sequencing Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of the key players in the global next-generation sequencing market Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

Segments for Global Next Generation Sequencing Market

The global next generation sequencing market has been segmented on the basis of technology, service and product, application and end users.

On the basis of type of technology, the market has been classified as whole genome sequencing, whole exome sequencing, CHIP sequencing, methyl sequencing, targeted resequencing, RNA sequencing and de novo sequencing.

On the basis of type of service & product, the market has been classified as sample preparation, consumables, platforms and services for platforms, sequencing services. The sample preparation is segmented into DNA fragmentation, end repair, A-tailing, and size selection, library preparation & target enrichment, and quality control. The platforms and services for platforms are segmented into Illumina, thermo fisher scientific, pacific biosciences, oxford nanopore technologies and other next-generation sequencing platforms.

On the basis of type of application, the market has been classified as drug discovery, genetic screening, diagnostics, agriculture and animal research and others.

On the basis of type of end-users, the market has been academic institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies and other end users.

Regional Analysis for Global Next Generation Sequencing Market

lobal Next Generation Sequencing Market Share, by Region, 2017 (%)

In the next generation sequencing market, North America is anticipated to account for the largest market share. Factors such as a rise in customer requirements and increased competition among players through acquisitions and mergers are anticipated to drive the growth of the market. The rise in the number of funds and initiatives adopted by the government to decrease the cases of cancer and to improve the healthcare sector is likely to grow the market.

The European market is expected to hold the second largest market share due to the presence of pioneering next-generation sequencing technology, a very refined and educated population interested in next-generation technology (NGS). Nevertheless, the diverse rules and regulations and a fragmented market all over Europe are likely to restrain the growth of the market.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising investments by pharmaceutical companies.

The market in the Middle East and Africa is expected to account for the smallest share of the next generation sequencing market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/6354

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Browse Complete Report @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.